Instituto Rosenbusch S.A. (BCBA:ROSE)
161.00
+14.50 (9.90%)
At close: Oct 31, 2025
Instituto Rosenbusch Company Description
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina.
The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis.
It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals.
The company was founded in 1917 and is based in Buenos Aires, Argentina.
Instituto Rosenbusch S.A.
| Country | Argentina |
| Founded | 1917 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Rodolfo Martín Balestrini |
Contact Details
Address: Hipólito Yrigoyen 1628 (C1089AAF) Buenos Aires, 1136 Argentina | |
| Phone | 54 11 4304 0051 |
| Website | rosenbusch.com |
Stock Details
| Ticker Symbol | ROSE |
| Exchange | Buenos Aires Stock Exchange |
| Stock Type | Common Stock |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | ARS |
| ISIN Number | ARROSE010025 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Rodolfo Martín Balestrini | Chairman of the Board of Directors and President |
| Oscar Echeverria | Financial Manager |